Eton Pharmaceuticals, Inc. ETON Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s accrued liabilities, current?
- Eton Pharmaceuticals, Inc. (ETON) reported accrued liabilities, current of $7.75M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s accrued liabilities, current changed year-over-year?
- Eton Pharmaceuticals, Inc.'s accrued liabilities, current increased by 2.7% year-over-year, from $7.54M to $7.75M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s accrued liabilities, current has grown at a 51.7% compound annual growth rate (CAGR), from $1.17M to $9.41M.